Yoshiaki Uyama,
PhD
Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board
Director, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency
Dr. Uyama is currently Director, Office of Medical Informatics and Epidemiology, Pharmaceuticals & Medical Devices Agency, Japan. He received his PhD degree and became a research fellow for the promotion of science within Japanese society. He was a post-doctoral fellow at the University of Calgary (Canada) from 1994 – 1995 and researcher in the Tokyo Metropolitan Institute of Medical Science from 1995 – 1998).
Dr. Uyama joined the Ministry of Health and Welfare (now the Ministry of Health, Labour and Welfare) as a technical officer in 1998. In 2001, he started new drug review in the Pharmaceuticals and Medical Devices Evaluation Center of National Institute of Health Science, and has continued his career in drug review for the Pharmaceuticals and Medical Devices Agency since April 2004. His extensive experience in the review and safety assessment of new drugs includes serving as the Review Director (2007 – 2010); International Conference on Harmonisation Technical Coordinator (2004 – 2009); ICH E15 and E16 topic leader (2011 – 2012); Division Director for Regulatory Science Research (2011 – 2012); Division Director of Review Planning and Pharmaceutical Affairs Consultation (2012 –2013); Director, Division of Epidemiology (2014); and as Rapporteur of the International Conference on Harmonisation E17 Expert Working Group (2014). Dr. Uyama received his PhD degree from the Nagoya City University in 1994.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China